Cited by 193Natural Antidiabetic Agents StudiesSeaweed-derived Bioactive CompoundsDiabetes, Cardiovascular Risks, and Lipoproteins

Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus

Parikh, Panam, Mani, Uliyar, Iyer, Uma·2001·Journal of Medicinal Food

Abstract

Spirulina, with its high concentration of functional nutrients, is emerging as an important therapeutic food. This study aimed to evaluate the hypoglycemic and hypolipidemic role of Spirulina. Twenty-five subjects with type 2 diabetes mellitus were randomly assigned to receive Spirulina (study group) or to form the control group. At baseline, the control and study groups were matched for various variables. The efficacy of Spirulina supplementation (2 g/day for 2 months) was determined using the preintervention and postintervention blood glucose levels, glycosylated hemoglobin (HbA(1c)) levels, and lipid profiles of the diabetic subjects. Two-month supplementation with Spirulina resulted in an appreciable lowering of fasting blood glucose and postprandial blood glucose levels. A significant reduction in the HbA(1c) level was also observed, indicating improved long-term glucose regulation. With regard to lipids, triglyceride levels were significantly lowered. Total cholesterol (TC) and its fraction, low-density lipoprotein cholesterol (LDL-C), exhibited a fall coupled with a marginal increase in the level of high-density lipoprotein cholesterol (HDL-C). As a result, a significant reduction in the atherogenic indices, TC:HDL-C and LDL-C: HDL-C, was observed. The level of apolipoprotein B registered a significant fall together with a significant increment in the level of apolipoprotein A1. Therefore, a significant and favorable increase in the ratio of A1:B was also noted. These findings suggest the beneficial effect of Spirulina supplementation in controlling blood glucose levels and in improving the lipid profile of subjects with type 2 diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1089/10966200152744463

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Parikh et al found in 25 type 2 diabetics that 2 g/day spirulina for 2 months lowered fasting blood glucose, postprandial blood glucose, HbA1c, TG, LDL-C, TC, atherogenic indices, apolipoprotein B, and increased apolipoprotein A1.

    “Similarly, Parikh et al enrolled 25 type 2 diabetics and established that 2 g/day of spirulina for 2 months in this population can lower fasting blood glucose by 19.3 mg (p<0.05), postprandial blood glucose by 16.1 mg (p<0.05), HbA1c by 1.0% (p<0.05) in addition to lowering in TG by 6.4 mg, LDL-C by 7.1 mg, TC by 21.3 mg (p<0.05) and overall reduction in atherogenic indices of TC:HDL-C from 5.4±1.”
  • Some studies found decreased levels of glucose or HOMA-IR after Spirulina supplementation in healthy volunteers, subjects with NAFLD, T2D, and HIV-infected antiretroviral-naïve patients.

    “some studies found also decreased levels of glucose or HOMA-IR after Spirulina supplementation in healthy volunteers [12], in subjects with NAFLD [130], T2D [138], and HIV-infected antiretroviral-naïve patients [102, 135].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Parikh, P., Mani, U., & Iyer, U.
Affiliations
Maharaja Sayajirao University of Baroda (IN)
Venue
Journal of Medicinal Food
Published
2001-12
Volume
4
Issue
4
Pages
193-199
ISSN
  • 1096-620X (ISSN-L)
  • 1557-7600
OpenAlex
W1594930126
Cited by
193
References
21
Citations by year
2026: 4 · 2025: 9 · 2024: 15 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 14 · 2019: 8 · 2018: 15 · 2017: 8 · 2016: 11 · 2015: 13 · 2014: 7 · 2013: 9 · 2012: 6
FWCI
0.45
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Food (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
Spirulina, type 2 diabetes, glycemic control, hypoglycemic effect, hypolipidemic effect, lipid profile, HbA1c, triglycerides, LDL cholesterol, HDL cholesterol, apolipoprotein B, apolipoprotein A-I, functional food supplementation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review